Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Short-term Investments (2016 - 2021)

Historic Short-term Investments for Sanofi (SNY) over the last 13 years, with Q4 2021 value amounting to $12.5 million.

  • Sanofi's Short-term Investments fell 9318.24% to $12.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $12.5 million, marking a year-over-year decrease of 9318.24%. This contributed to the annual value of $12.9 million for FY2021, which is 9263.54% down from last year.
  • Latest data reveals that Sanofi reported Short-term Investments of $12.5 million as of Q4 2021, which was down 9318.24% from $182.9 million recorded in Q4 2020.
  • Over the past 5 years, Sanofi's Short-term Investments peaked at $227.1 million during Q4 2018, and registered a low of $12.5 million during Q4 2021.
  • For the 5-year period, Sanofi's Short-term Investments averaged around $132.0 million, with its median value being $147.0 million (2019).
  • In the last 5 years, Sanofi's Short-term Investments soared by 17086.46% in 2017 and then tumbled by 9318.24% in 2021.
  • Quarter analysis of 5 years shows Sanofi's Short-term Investments stood at $90.7 million in 2017, then soared by 150.53% to $227.1 million in 2018, then plummeted by 35.28% to $147.0 million in 2019, then rose by 24.42% to $182.9 million in 2020, then tumbled by 93.18% to $12.5 million in 2021.
  • Its Short-term Investments stands at $12.5 million for Q4 2021, versus $182.9 million for Q4 2020 and $147.0 million for Q4 2019.